Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03802006
Other study ID # L-2018-346
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 15, 2018
Est. completion date December 15, 2020

Study information

Verified date October 2018
Source Seoul National University Hospital
Contact Tea Kyong Kim, M.D.,Ph. D.
Phone 82-2-870-2519
Email ktkktk@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Investigators assess the gastric contents by ultrasonography in fasted patients with previous subtotal gastrectomy.


Description:

Investigators evaluate the gastric contents by ultrasonography in fasted patients with previous subtotal gastrectomy, quantitatively and qualitatively. The frequency of visualization fully will be also analyzed.


Recruitment information / eligibility

Status Recruiting
Enrollment 24
Est. completion date December 15, 2020
Est. primary completion date November 15, 2020
Accepts healthy volunteers No
Gender All
Age group 20 Years to 90 Years
Eligibility Inclusion Criteria:

- The preoperative fasted patients with previous subtotal gastrectomy

Exclusion Criteria:

- Other anatomical abnormality or mass of stomach except gastrectomy

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Ultrasound assessment of gastric content
Ultrasound assessment of gastric body is performed

Locations

Country Name City State
Korea, Republic of Seoul National University Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of full cross section image The gastric remnant body is assessed by ultrasound and the incidence of cross sectional image visualized fully is evaluated Before the induction of anesthesia
Secondary Type of gastric content assessed by gastric ultrasound The type of gastric content is assessed by gastric ultrasound; solid, fluid, empty Before the induction of anesthesia
Secondary Cross section area of stomach body assessed by gastric ultrasound Cross section area is assessed by gastric ultrasound in the supine and right lateral positions Before the induction of anesthesia
Secondary Incidence of full stomach It is determined if the contents is solid or the amount of fluid is large. Before the induction of anesthesia
See also
  Status Clinical Trial Phase
Completed NCT03941288 - Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia Phase 2
Terminated NCT03285308 - A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01 Phase 3
Completed NCT00733551 - Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects. Phase 1
Completed NCT01650714 - Endoscopic Full Thickness Biopsy, Gastric Wall. N/A
Completed NCT01452815 - Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis Phase 2
Completed NCT01039974 - GSK962040 Drug-drug Interaction Study With Ketoconazole Phase 1
Terminated NCT04844190 - Use of EndoFLIP and Manometry Prior to G-POEM N/A
Enrolling by invitation NCT06215547 - Medtronic Enterra II Neurostimulator N/A
Completed NCT04026997 - A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis Phase 2
Completed NCT00562848 - A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040 Phase 1
Enrolling by invitation NCT04207996 - Vagus Nerve Response in Gastroparesis Patients
Completed NCT04607304 - ABCA2 GIRMS Analytical Validation Clinical Performance Study N/A
Recruiting NCT06068114 - Gastric Pathophysiology in Diabetes
Completed NCT03259841 - Ultrasound Assessment of Gastric Contents in Fasted Patient Undergoing Cholecystectomy
Active, not recruiting NCT04300127 - Pioglitazone for Idiopathic Gastroparesis Early Phase 1
Recruiting NCT01696734 - Domperidone in Treating Patients With Gastrointestinal Disorders Phase 3
Terminated NCT04635306 - 13C-Spirulina Nitrogen Content GEBT Study N/A
Withdrawn NCT02420925 - Effect of Celiac Plexus Block on Gastric Emptying and Symptoms Caused by Gastroparesis N/A
Recruiting NCT00777439 - Domperidone for Refractory Gastrointestinal Disorders N/A
Terminated NCT00760461 - Domperidone in Refractory Gastroparesis Phase 2